| 000 | 01765 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516215109.0 | ||
| 264 | 0 | _c20150330 | |
| 008 | 201503s 0 0 eng d | ||
| 022 | _a1531-8257 | ||
| 024 | 7 |
_a10.1002/mds.25736 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKelly, Leo P | |
| 245 | 0 | 0 |
_aProgression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson's disease. _h[electronic resource] |
| 260 |
_bMovement disorders : official journal of the Movement Disorder Society _cJul 2014 |
||
| 300 |
_a999-1009 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBrain _xmetabolism |
| 650 | 0 | 4 | _aChromatography, Gas |
| 650 | 0 | 4 |
_aColon _xdrug effects |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 |
_aGastrointestinal Agents _xurine |
| 650 | 0 | 4 | _aLinear Models |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 |
_aParkinson Disease _xetiology |
| 650 | 0 | 4 |
_aPermeability _xdrug effects |
| 650 | 0 | 4 |
_aPolysaccharides _xtoxicity |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTyrosine 3-Monooxygenase _xmetabolism |
| 650 | 0 | 4 |
_aVagus Nerve _xmetabolism |
| 650 | 0 | 4 |
_aalpha-Synuclein _xmetabolism |
| 700 | 1 | _aCarvey, Paul M | |
| 700 | 1 | _aKeshavarzian, Ali | |
| 700 | 1 | _aShannon, Kathleen M | |
| 700 | 1 | _aShaikh, Maliha | |
| 700 | 1 | _aBakay, Roy A E | |
| 700 | 1 | _aKordower, Jeffrey H | |
| 773 | 0 |
_tMovement disorders : official journal of the Movement Disorder Society _gvol. 29 _gno. 8 _gp. 999-1009 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/mds.25736 _zAvailable from publisher's website |
| 999 |
_c23889497 _d23889497 |
||